瓣膜-话题@MedSci

#瓣膜#

305篇内容 | 2500人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1583624, encodeId=4cac158362421, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JACC：二尖瓣返流的经导管瓣膜修复治疗, objectType=article, longId=174560, objectId=ad1e1e4560eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad1e1e4560eb, replyNumber=0, likeNumber=67, createdTime=2019-07-02, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad1e1e4560eb, moduleTitle=JACC：二尖瓣返流的经导管瓣膜修复治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad1e1e4560eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583623, encodeId=700b15836236e, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=Heart：瓣膜性心脏病和生物人工心脏瓣膜的房颤患者口服抗凝剂疗效, objectType=article, longId=168552, objectId=9d6b1685522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d6b1685522f, replyNumber=0, likeNumber=64, createdTime=2019-06-18, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d6b1685522f, moduleTitle=Heart：瓣膜性心脏病和生物人工心脏瓣膜的房颤患者口服抗凝剂疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d6b1685522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583622, encodeId=edd415836227b, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, objectType=article, longId=166308, objectId=02b116630814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b116630814, replyNumber=0, likeNumber=67, createdTime=2019-05-19, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b116630814, moduleTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02b116630814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583621, encodeId=8c5b1583621f9, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, objectType=article, longId=165554, objectId=60da165554b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60da165554b1, replyNumber=0, likeNumber=36, createdTime=2019-05-08, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60da165554b1, moduleTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60da165554b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583620, encodeId=ef101583620d2, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=NEJM：自膨胀瓣膜TAVR在低危主动脉瓣狭窄患者中的疗效, objectType=article, longId=165360, objectId=fe0e165360c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe0e165360c1, replyNumber=0, likeNumber=63, createdTime=2019-05-05, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe0e165360c1, moduleTitle=NEJM：自膨胀瓣膜TAVR在低危主动脉瓣狭窄患者中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe0e165360c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583619, encodeId=8c6115836195c, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=NEJM：低风险主动脉瓣狭窄患者球囊扩张瓣膜的TAVR疗效分析, objectType=article, longId=165359, objectId=0bd716535948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bd716535948, replyNumber=0, likeNumber=62, createdTime=2019-05-05, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bd716535948, moduleTitle=NEJM：低风险主动脉瓣狭窄患者球囊扩张瓣膜的TAVR疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bd716535948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583618, encodeId=ab571583618dd, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JACC：TAVR预扩张与无预扩张自扩张瓣膜植入的比较, objectType=article, longId=164717, objectId=f3b4164e172d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3b4164e172d, replyNumber=0, likeNumber=58, createdTime=2019-04-23, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3b4164e172d, moduleTitle=JACC：TAVR预扩张与无预扩张自扩张瓣膜植入的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3b4164e172d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583617, encodeId=6a97158361e60, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=Circulation子刊研究称，“不开胸”置入的瓣膜耐久性达7年以上, objectType=article, longId=164394, objectId=6a32164394bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a32164394bd, replyNumber=0, likeNumber=50, createdTime=2019-04-18, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a32164394bd, moduleTitle=Circulation子刊研究称，“不开胸”置入的瓣膜耐久性达7年以上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a32164394bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583616, encodeId=175f1583616f6, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=Eur Heart J：经导管瓣膜治疗患者的虚弱性和相关结局, objectType=article, longId=164280, objectId=152c164280ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=152c164280ca, replyNumber=0, likeNumber=78, createdTime=2019-04-16, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=152c164280ca, moduleTitle=Eur Heart J：经导管瓣膜治疗患者的虚弱性和相关结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=152c164280ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583615, encodeId=21c715836153a, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JAHA：经导管主动脉瓣膜置换术后他汀类药物使用与死亡率的关系, objectType=article, longId=163713, objectId=7ca2163e1360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ca2163e1360, replyNumber=0, likeNumber=24, createdTime=2019-04-07, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ca2163e1360, moduleTitle=JAHA：经导管主动脉瓣膜置换术后他汀类药物使用与死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ca2163e1360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583614, encodeId=33ba158361466, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JACC：评估一种新型自扩张经导管心脏瓣膜CENTERA-EU试验的1年结局, objectType=article, longId=163642, objectId=c3b2163642de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3b2163642de, replyNumber=0, likeNumber=88, createdTime=2019-04-06, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3b2163642de, moduleTitle=JACC：评估一种新型自扩张经导管心脏瓣膜CENTERA-EU试验的1年结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3b2163642de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583613, encodeId=da3a1583613cb, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JACC：预扩张vs无预扩张植入自扩张瓣膜的TAVR, objectType=article, longId=163345, objectId=efd9163345f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efd9163345f1, replyNumber=0, likeNumber=64, createdTime=2019-04-02, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efd9163345f1, moduleTitle=JACC：预扩张vs无预扩张植入自扩张瓣膜的TAVR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efd9163345f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583612, encodeId=b01e158361266, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JACC：使用下一代自扩张瓣膜的经导管主动脉瓣置换术, objectType=article, longId=162218, objectId=bf0816221828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf0816221828, replyNumber=0, likeNumber=28, createdTime=2019-03-14, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf0816221828, moduleTitle=JACC：使用下一代自扩张瓣膜的经导管主动脉瓣置换术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf0816221828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583611, encodeId=f2a1158361160, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JAMA Cardiol：机械性瓣膜vs自扩张瓣膜经导管主动脉瓣置换术后的2年结局, objectType=article, longId=161843, objectId=45b8161843ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45b8161843ce, replyNumber=0, likeNumber=57, createdTime=2019-03-09, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45b8161843ce, moduleTitle=JAMA Cardiol：机械性瓣膜vs自扩张瓣膜经导管主动脉瓣置换术后的2年结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45b8161843ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583610, encodeId=be97158361044, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JACC：经颈动脉通路使用Sapien 3生物瓣膜的经导管主动脉瓣置换术, objectType=article, longId=161698, objectId=c5b71616987e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5b71616987e, replyNumber=0, likeNumber=42, createdTime=2019-03-07, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5b71616987e, moduleTitle=JACC：经颈动脉通路使用Sapien 3生物瓣膜的经导管主动脉瓣置换术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5b71616987e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583609, encodeId=97e4158360918, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=TAVR 治疗二叶式主动脉瓣狭窄：主动脉根部形态影响瓣膜置入, objectType=article, longId=161676, objectId=b6051616e631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6051616e631, replyNumber=0, likeNumber=82, createdTime=2019-03-06, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6051616e631, moduleTitle=TAVR 治疗二叶式主动脉瓣狭窄：主动脉根部形态影响瓣膜置入, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6051616e631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583608, encodeId=0057158360841, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=Heart：瓣膜面积和过高估计的主动脉瓣狭窄风险, objectType=article, longId=160261, objectId=deb816026127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deb816026127, replyNumber=0, likeNumber=0, createdTime=2019-02-19, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deb816026127, moduleTitle=Heart：瓣膜面积和过高估计的主动脉瓣狭窄风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deb816026127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583607, encodeId=3c70158360efc, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估, objectType=article, longId=158248, objectId=3c941582481a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c941582481a, replyNumber=0, likeNumber=28, createdTime=2019-01-18, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c941582481a, moduleTitle=2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c941582481a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583606, encodeId=86a4158360688, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JACC：比较不同经导管心脏瓣膜设计的瓣中瓣TAVR及生物瓣折断, objectType=article, longId=157686, objectId=7a1215e68621, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a1215e68621, replyNumber=0, likeNumber=62, createdTime=2019-01-11, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a1215e68621, moduleTitle=JACC：比较不同经导管心脏瓣膜设计的瓣中瓣TAVR及生物瓣折断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a1215e68621)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1583605, encodeId=949c1583605c4, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, objectTitle=JAHA：经导管主动脉瓣膜置换等待时间与术后早期结局之间的关系, objectType=article, longId=157477, objectId=35ce15e47719, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35ce15e47719, replyNumber=0, likeNumber=57, createdTime=2019-01-08, rootId=0, userName=12498e5fm17(暂无昵称), userId=58dc16986228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35ce15e47719, moduleTitle=JAHA：经导管主动脉瓣膜置换等待时间与术后早期结局之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35ce15e47719)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

瓣膜

2020-05-29

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JACC：二尖瓣返流的经导管瓣膜修复治疗

2019-07-02

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

Heart：瓣膜性心脏病和生物人工心脏瓣膜的房颤患者口服抗凝剂疗效

2019-06-18

爆笑小医 (审核中...)

前往app查看评论内容

#瓣膜#

Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估

2019-05-19

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗

2019-05-08

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

NEJM：自膨胀瓣膜TAVR在低危主动脉瓣狭窄患者中的疗效

2019-05-05

docwu2019 (审核中...)

前往app查看评论内容

#瓣膜#

NEJM：低风险主动脉瓣狭窄患者球囊扩张瓣膜的TAVR疗效分析

2019-05-05

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JACC：TAVR预扩张与无预扩张自扩张瓣膜植入的比较

2019-04-23

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

Circulation子刊研究称，“不开胸”置入的瓣膜耐久性达7年以上

2019-04-18

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

Eur Heart J：经导管瓣膜治疗患者的虚弱性和相关结局

2019-04-16

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JAHA：经导管主动脉瓣膜置换术后他汀类药物使用与死亡率的关系

2019-04-07

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JACC：评估一种新型自扩张经导管心脏瓣膜CENTERA-EU试验的1年结局

2019-04-06

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JACC：预扩张vs无预扩张植入自扩张瓣膜的TAVR

2019-04-02

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JACC：使用下一代自扩张瓣膜的经导管主动脉瓣置换术

2019-03-14

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JAMA Cardiol：机械性瓣膜vs自扩张瓣膜经导管主动脉瓣置换术后的2年结局

2019-03-09

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JACC：经颈动脉通路使用Sapien 3生物瓣膜的经导管主动脉瓣置换术

2019-03-07

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

TAVR 治疗二叶式主动脉瓣狭窄：主动脉根部形态影响瓣膜置入

2019-03-06

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

Heart：瓣膜面积和过高估计的主动脉瓣狭窄风险

2019-02-19

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估

2019-01-18

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JACC：比较不同经导管心脏瓣膜设计的瓣中瓣TAVR及生物瓣折断

2019-01-11

12498e5fm17(暂无昵称) (审核中...)

前往app查看评论内容

#瓣膜#

JAHA：经导管主动脉瓣膜置换等待时间与术后早期结局之间的关系

2019-01-08

科室
- - 订阅+
  - 更多科室
工具
服务